Delivery Order SPE2DB22D1017-SPE2DB25FYSGB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by October 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count) under a firm fixed price contract. This non-set-aside award, issued on July 17, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,454.56 by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Imbruvica 140 mg tablets (28-count package). This firm fixed-price contract, which is not a set-aside award, is set to conclude on October 16, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, PA. The award represents a...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count packaging) under a firm fixed price contract type. The delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) under a firm fixed-price contract valued at $22,727.25, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract represents a child delivery order issued against AmerisourceBergen's larger indefinite delivery vehicle with the DLA. The pharmaceutical distributor will perform under this contract at its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with delivery to Conshohocken, Pennsylvania. This contract, awarded on August 4, 2025, utilizes a firm fixed-price structure with an ultimate completion date of August 25, 2025. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSGBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,303.04 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) with a firm fixed price contract type. The order is set to be completed by October 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC functions as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products, medical supplies, brand-name and generic medications, and specialty healthcare commodities across multiple therapeutic domains. Through this delivery order, the company continues to provide essential pharmaceutical support to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard under a competitively awarded contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 9/29/25 |